Nuveen Asset Management’s Arcutis Biotherapeutics ARQT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $5.11M | Sell |
366,886
-440,764
| -55% | -$6.14M | ﹤0.01% | 1973 |
|
|
2024
Q3 | $7.51M | Buy |
807,650
+72,608
| +10% | +$675K | ﹤0.01% | 1780 |
|
|
2024
Q2 | $6.84M | Buy |
735,042
+486,856
| +196% | +$4.53M | ﹤0.01% | 1787 |
|
|
2024
Q1 | $2.46M | Buy |
248,186
+34,351
| +16% | +$340K | ﹤0.01% | 2303 |
|
|
2023
Q4 | $691K | Sell |
213,835
-5,342
| -2% | -$17.3K | ﹤0.01% | 2893 |
|
|
2023
Q3 | $1.16M | Buy |
219,177
+6,481
| +3% | +$34.4K | ﹤0.01% | 2518 |
|
|
2023
Q2 | $2.03M | Buy |
212,696
+108,935
| +105% | +$1.04M | ﹤0.01% | 2334 |
|
|
2023
Q1 | $1.14M | Sell |
103,761
-1,025
| -1% | -$11.3K | ﹤0.01% | 2562 |
|
|
2022
Q4 | $1.55M | Sell |
104,786
-428,089
| -80% | -$6.34M | ﹤0.01% | 2492 |
|
|
2022
Q3 | $10.2M | Buy |
532,875
+171,732
| +48% | +$3.28M | ﹤0.01% | 1463 |
|
|
2022
Q2 | $7.7M | Buy |
361,143
+144,763
| +67% | +$3.08M | ﹤0.01% | 1682 |
|
|
2022
Q1 | $3.57M | Buy |
216,380
+5,641
| +3% | +$93K | ﹤0.01% | 2243 |
|
|
2021
Q4 | $4.37M | Sell |
210,739
-8,653
| -4% | -$179K | ﹤0.01% | 2198 |
|
|
2021
Q3 | $4.97M | Sell |
219,392
-44,454
| -17% | -$1.01M | ﹤0.01% | 2210 |
|
|
2021
Q2 | $7.2M | Buy |
263,846
+40,838
| +18% | +$1.11M | ﹤0.01% | 2060 |
|
|
2021
Q1 | $6.45M | Buy |
223,008
+42,366
| +23% | +$1.23M | ﹤0.01% | 2041 |
|
|
2020
Q4 | $5.08M | Buy |
180,642
+112,262
| +164% | +$3.16M | ﹤0.01% | 2068 |
|
|
2020
Q3 | $2M | Buy |
68,380
+24,425
| +56% | +$715K | ﹤0.01% | 2388 |
|
|
2020
Q2 | $1.33M | Buy |
43,955
+5,059
| +13% | +$153K | ﹤0.01% | 2500 |
|
|
2020
Q1 | $1.16M | Buy |
+38,896
| New | +$1.16M | ﹤0.01% | 2448 |
|